HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark A Prendergast Selected Research

MHP 133

7/2007MHP-133, a drug with multiple CNS targets: potential for neuroprotection and enhanced cognition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark A Prendergast Research Topics

Disease

5Alcoholism (Alcohol Abuse)
11/2015 - 05/2005
2Substance-Related Disorders (Drug Abuse)
01/2018 - 04/2015
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2013 - 07/2007
2Dementia (Dementias)
05/2011 - 12/2004
2Alzheimer Disease (Alzheimer's Disease)
07/2007 - 11/2005
1Contusions
12/2023
1Spinal Cord Injuries (Spinal Cord Injury)
12/2023
1Hyperalgesia
12/2023
1Hemorrhage
12/2023
1Shock
09/2021
1Tobacco Use Disorder (Nicotine Dependence)
12/2018
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2018
1Neoplasms (Cancer)
01/2017
1Tremor (Tremors)
08/2013
1Neurocognitive Disorders (Clerambault Syndrome)
01/2013
1Memory Disorders (Memory Loss)
12/2008
1Poisoning
09/2007
1Amyloid Plaque
11/2005
1Cognitive Dysfunction
05/2005
1Nervous System Diseases (Neurological Disorders)
01/2004
1Infections
01/2004
1Weight Loss (Weight Reduction)
10/2002

Drug/Important Bio-Agent (IBA)

3GlucocorticoidsIBA
09/2021 - 05/2005
2Ethanol (Ethyl Alcohol)IBA
12/2023 - 05/2005
2(11R,13S,17S)- 11- (1,3- benzodioxol- 5- yl)- 17- hydroxy- 13- methyl- 17- prop- 1- ynyl- 1,2,6,7,8,11,12,14,15,16- decahydrocyclopenta(a)phenanthren- 3- oneIBA
09/2021 - 01/2018
2Proteins (Proteins, Gene)FDA Link
11/2015 - 05/2011
2Mifepristone (RU 486)FDA Link
08/2013 - 12/2008
2Transcription Factors (Transcription Factor)IBA
12/2004 - 01/2004
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
12/2004 - 01/2004
1Biomarkers (Surrogate Marker)IBA
12/2023
1Fentanyl (Sublimaze)FDA LinkGeneric
09/2021
1SalicylatesIBA
01/2017
1A-130A (A 130)IBA
01/2017
1SaltsIBA
01/2017
1Phenol (Carbolic Acid)FDA Link
01/2017
1SodiumIBA
01/2017
1Cocaine (Cocaine HCl)IBA
04/2015
1Amino AcidsFDA Link
05/2013
1Lobeline (Smokeless)IBA
08/2012
1cytisineIBA
08/2012
1sazetidine-AIBA
08/2012
1CP 601932IBA
08/2012
1PF 4575180IBA
08/2012
1Varenicline (Chantix)FDA Link
08/2012
1Ion Channels (Ion Channel)IBA
08/2012
1MecamylamineIBA
08/2012
1Cholinergic ReceptorsIBA
08/2012
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
08/2012
1Trans-Activators (Trans-Acting Factor)IBA
05/2011
1Cholinergic Agents (Cholinergics)IBA
09/2007
1OrganophosphatesIBA
09/2007
1PesticidesIBA
09/2007
1MHP 133IBA
07/2007
1Peptides (Polypeptides)IBA
11/2005
1Amyloid beta-PeptidesIBA
11/2005
1Hormones (Hormone)IBA
05/2005
1Viral ProteinsIBA
12/2004
1N-Methylaspartate (NMDA)IBA
01/2004
1PolyaminesIBA
01/2004
1Glutamate Receptors (Glutamate Receptor)IBA
01/2004
1Fluoxetine (Prozac)FDA LinkGeneric
10/2002

Therapy/Procedure

2Drug Therapy (Chemotherapy)
12/2018 - 08/2012
1Self Administration (Administration, Self)
01/2018
1Therapeutics
01/2013